| GILD |
Gilead Sciences, Inc. |
139.54B |
5.36% |
|
|
|
|
|
112.05 |
0.23% |
32.76% |
76.20% |
|---|
| UTHR |
United Therapeutics Corporation |
13.85B |
5.03% |
|
|
|
|
|
308.27 |
0.42% |
35.09% |
77.41% |
|---|
| NTRA |
Natera, Inc. |
19.12B |
5.02% |
|
|
|
|
|
141.41 |
-1.76% |
53.42% |
44.70% |
|---|
| BIIB |
Biogen Inc. |
20.03B |
4.91% |
|
|
|
|
|
136.84 |
-1.11% |
9.10% |
67.41% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
68.18B |
4.90% |
|
|
|
|
|
634.23 |
-0.49% |
44.03% |
94.27% |
|---|
| INCY |
Incyte Corporation |
11.72B |
4.85% |
|
|
|
|
|
60.55 |
-0.08% |
42.37% |
42.94% |
|---|
| ILMN |
Illumina, Inc. |
12.57B |
4.85% |
|
|
|
|
|
79.34 |
-0.83% |
56.13% |
62.45% |
|---|
| AMGN |
Amgen Inc. |
167.37B |
4.60% |
|
|
|
|
|
311.55 |
1.50% |
35.26% |
42.64% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
11.03B |
3.08% |
|
|
|
|
|
110.60 |
-2.26% |
34.71% |
34.56% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
1.57B |
2.98% |
|
|
|
|
|
7.50 |
-4.58% |
50.70% |
29.96% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
6.19B |
2.98% |
|
|
|
|
|
63.82 |
-9.36% |
71.87% |
33.89% |
|---|
| EXAS |
Exact Sciences Corporation |
8.04B |
2.93% |
|
|
|
|
|
43.29 |
-0.85% |
63.70% |
45.47% |
|---|
| QGEN |
Qiagen N.V. |
8.74B |
2.92% |
|
|
|
|
|
40.15 |
0.75% |
48.39% |
42.39% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
13.49B |
2.89% |
|
|
|
|
|
70.69 |
-1.05% |
33.04% |
40.07% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.77B |
2.88% |
|
|
|
|
|
16.61 |
-2.69% |
52.38% |
70.87% |
|---|
| MNKD |
MannKind Corporation |
1.53B |
2.85% |
|
|
|
|
|
5.03 |
0.00% |
67.81% |
52.45% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
2.95B |
2.85% |
|
|
|
|
|
24.25 |
-1.78% |
42.34% |
51.43% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.88B |
2.83% |
|
|
|
|
|
63.81 |
-0.05% |
37.56% |
28.18% |
|---|
| TECH |
Bio-Techne Corporation |
9.27B |
2.76% |
|
|
|
|
|
58.63 |
-0.17% |
40.49% |
64.92% |
|---|
| VCYT |
Veracyte, Inc. |
2.31B |
2.74% |
|
|
|
|
|
29.65 |
-1.56% |
62.23% |
58.50% |
|---|
| RPRX |
Royalty Pharma plc |
13.49B |
2.71% |
|
|
|
|
|
31.13 |
-0.77% |
31.94% |
70.50% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.66B |
2.68% |
|
|
|
|
|
88.51 |
-0.24% |
66.68% |
56.20% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
939.84M |
2.66% |
|
|
|
|
|
29.85 |
0.47% |
55.89% |
48.38% |
|---|
| TGTX |
TG Therapeutics, Inc. |
6.19B |
2.64% |
|
|
|
|
|
39.43 |
-1.08% |
62.48% |
42.24% |
|---|
| XNCR |
Xencor, Inc. |
749.71M |
2.62% |
|
|
|
|
|
10.64 |
-5.25% |
81.40% |
81.36% |
|---|
| EXEL |
Exelixis, Inc. |
10.33B |
2.61% |
|
|
|
|
|
36.92 |
0.60% |
35.76% |
39.96% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
5.69B |
2.50% |
|
|
|
|
|
116.63 |
-1.60% |
49.12% |
18.29% |
|---|
| CDNA |
CareDx, Inc |
983.81M |
2.46% |
|
|
|
|
|
17.75 |
-1.17% |
110.71% |
43.07% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.97B |
2.41% |
|
|
|
|
|
48.36 |
-1.06% |
68.70% |
4.79% |
|---|
| MYGN |
Myriad Genetics, Inc. |
809.91M |
2.40% |
|
|
|
|
|
8.87 |
-0.11% |
60.35% |
69.37% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.08% |
|
|
|
|
|
|
|
|
|
|---|